Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07483294
PHASE4

Cerebellum-based Imaging Neural Markers for Antipsychotic Response

Sponsor: Northwell Health

View on ClinicalTrials.gov

Summary

This study plans to collect 120 patients with first-episode psychosis. Participants will receive multimodal MRI scans (naturalistic fMRI, structural, diffusional) and comprehensive clinical assessments at baseline, and subsequently be treated with either risperidone or aripiprazole for 12 weeks. Clinical assessments for psychotic symptoms will be followed multiple times during the treatment until the 12th week. Data analysis will be conducted at the Psychiatric Research Unit of the Zucker Hillside Hospital.

Official title: Cerebellar-cortical Circuitry and Prediction of Treatment Response in Early Psychosis

Key Details

Gender

All

Age Range

15 Years - 40 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2025-11-01

Completion Date

2030-06-01

Last Updated

2026-05-26

Healthy Volunteers

No

Interventions

DRUG

risperidone

standard treatment, non-randomized

DRUG

aripiprazole

standard treatment, non-randomized

Locations (1)

Zucker Hillside Hospital

Glen Oaks, New York, United States